If you invest in the stock market, you must know the Laurus Labs share price targets for 2026, 2027, 2028, 2029, 2030, 2040, and 2050. Here, you will get detailed information regarding all your queries, such as its fundamentals, shareholdings, financial performance, future predictions, and more.
Table of Contents
About Laurus Labs Ltd
Laurus Labs is a well-known pharmaceutical company in India focused on generic drugs, active pharmaceutical ingredients, and contract manufacturing services. The company plays a key role in producing affordable healthcare products and life-saving medicines for the global market. It operates in areas such as antiviral drugs, oncology drugs, and biotech research. Laurus Labs is popular among investors looking for pharma stocks in India, fast-growing pharmaceutical companies, and long-term healthcare investment opportunities. With robust research, global exports, and quality manufacturing, the company supports the continued growth of the pharmaceutical and healthcare sectors.
Fundamental Analysis of Laurus Labs
- Market Cap: ₹59,436 Cr.
- High / Low: ₹1,145 / ₹572
- Stock P/E: 66.9
- Book Value: ₹98.2
- Dividend Yield: 0.18%
- ROCE: 17.7%
- ROE: 18.2%
- Face Value: ₹2
Laurus Labs Share Price Target 2026
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹900 and potentially achieve a maximum target of ₹1400 in the year 2026.
Laurus Labs Share Price Target 2027
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹1400 and potentially achieve a maximum target of ₹1800 in the year 2027.
Laurus Labs Share Price Target 2028
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹1800 and potentially achieve a maximum target of ₹2300 in the year 2028.
Laurus Labs Share Price Target 2029
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹2300 and potentially achieve a maximum target of ₹2700 in the year 2029.
Laurus Labs Share Price Target 2030
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹2700 and potentially achieve a maximum target of ₹3100 in the year 2030.
Laurus Labs Share Price Target 2040
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹5000 and potentially achieve a maximum target of ₹7000 in the year 2040.
Laurus Labs Share Price Target 2050
After analysing past price trends and market performance, it is estimated that the Laurus Labs stock price could reach a minimum of ₹9000 and potentially achieve a maximum target of ₹11000 in the year 2050.
Shareholding Pattern of Laurus Labs
- Retail and Others: 32.71%
- Promoters: 27.49%
- Foreign Institutions: 25.82%
- Mutual Funds: 11.22%
- Other Domestic Institutions: 2.74%
Should You Invest in Laurus Labs Stock?
| Year | Target Price (₹) |
|---|---|
| 2026 | 900–1400 |
| 2027 | 1400–1800 |
| 2028 | 1800–2300 |
| 2029 | 2300–2700 |
| 2030 | 2700–3100 |
| 2040 | 5000–7000 |
| 2050 | 13000–15000 |
Whether you should invest or not, it depends on the many factors. Let us know the risk and opportunities to invest in Laurus Labs stock.
Opportunities
- Strong global demand for generic drugs and API business supports long-term pharma stock growth.
- Focus on contract manufacturing and exports helps increase revenue and attract healthcare investors.
- A strong research and development pipeline supports future drug launches and business growth.
- Growing presence in the oncology and biotech segments improves high-margin opportunities.
- Cost-efficient manufacturing in India helps maintain competitive pricing in the global pharma market.
Risks
- Dependence on export markets due to changes in global demand and currency risks can impact revenue.
- Strict regulatory approvals and compliance issues could delay product launches and impact earnings.
- Pricing pressure in the generic drug market could reduce profit margins over time.
- High competition from large pharmaceutical companies could limit market share growth.
- Research and development costs could impact short-term profits and stock performance.
Key Competitors of Laurus Labs
Key competitors or peer companies of Laurus Labs are Divi’s Laboratories, Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, Lupin, Torrent Pharmaceuticals, Biocon, Alkem Laboratories, and Zydus Lifesciences.
Disclaimer: All the information provided in this article is for educational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
